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SCIENTIFIC OPINION 
Scientific Opinion on the efficacy of Lenziaren (iron, aqua carbonate 
hydroxyl oxo starch sucrose complex) as a feed additive for cats
1 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
This scientific output, published on 4 December 2014, replaces the earlier version published on 22 July 2014.
4 
ABSTRACT 
Lenziaren is a polynuclear Fe(III) starch–saccharose complex intended to be used in food for adult cats to reduce 
phosphate absorption in the gastrointestinal tract in order to prevent chronic kidney disease. The recommended 
minimum and maximum levels are 0.25 and 1.0 g/cat per day, equivalent to 5 000 and 20 000 mg/kg complete 
feed, respectively. In a previous opinion, the Panel on Additives and Products or Substances used in Animal 
Feed (FEEDAP) concluded that the minimum effective dose was 1 g/cat per day based on three studies which 
showed either a significant reduction in serum phosphorus or a reduction in urinary phosphate. Two of these 
studies showed an effect at 0.25 g/cat per day, while the third one only showed an effect at a level of 1 g/cat per 
day. The results of a new study submitted in this application showed that overall urine inorganic phosphorus 
concentrations  significantly  decreased  in  cats  receiving  Lenziaren  at  0.25 g/day  compared  with  the  control 
group. Therefore, considering the two previous studies, which showed an effect at 0.25 g/cat per day, and the 
results of the new study, the FEEDAP Panel considers that Lenziaren has the potential to be efficacious in 
binding intestinal phosphorus at the minimum recommended dose of 0.25 g/cat per day (equivalent to 5 g/kg 
complete feed). On balance, the Panel considers that the sex difference seen in the new study is an anomaly, 
possibly owing, as the applicant suggests, to selective feed intake. However, the Panel notes that sex differences 
were not explored in the remaining efficacy studies. The Panel still has the reservations expressed in the previous 
opinion regarding the value of the long-term use of the additive in healthy cats. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the efficacy 
of Lenziaren as a zootechnical additive for cats. 
The additive Lenziaren is a polynuclear Fe(III) starch–saccharose complex intended to be used in food 
for adult cats to reduce phosphate absorption in the gastrointestinal tract in order to prevent chronic 
kidney disease. The recommended minimum and maximum levels are 0.25 and 1.0 g/cat per day, 
equivalent to 5 and 20 g/kg complete feed, respectively. 
In a previous opinion, the FEEDAP Panel concluded that the minimum effective dose was 1 g/day, 
equivalent  to  20 g/kg  complete  feed,  based  on  three  studies  which  showed  either  a  significant 
reduction in serum phosphorus or a reduction in urinary phosphate. Two of these studies showed an 
effect at 0.25 g/day, while the third one only showed an effect at a level of 1 g/cat per day. The 
applicant provided a new study to support the efficacy of the additive at a dose of 0.25 g/cat per day. 
The  results  of  the  new  study  showed  that  overall  urine  inorganic  phosphorus  concentrations 
significantly decreased in cats receiving Lenziaren at 0.25 g/cat per day compared with the control 
group. However, differences between sexes were observed, which may be attributed, at least partially, 
to the fact that females seemed to avoid consumption of some of the test items. 
Therefore, considering the two previous studies, which showed an effect at 0.25 g/cat per day, and the 
results  of  the  new  study,  the  FEEDAP  Panel  considers  that  Lenziaren  has  the  potential  to  be 
efficacious in binding intestinal phosphorus at the minimum recommended dose of 0.25 g/cat per day 
(equivalent to 5 g/kg complete feed). On balance, the Panel considers that the sex difference seen in 
the new study is an anomaly, possibly owing, as the applicant suggests, to selective feed intake. 
However, the Panel notes that sex differences were not explored in the remaining efficacy studies. The 
Panel still has the reservations expressed in the previous opinion regarding the value of the long-term 
use of the additive in healthy cats. Lenziaren for cats 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
Regulation (EC) No 1831/2003
5 establishes rules governing the Community authorisation of additives 
for animal nutrit ion and in particular, Article 9 defines the terms of the authorisation by the 
Commission. 
The applicant Novartis
6 is seeking a Community authorisation of its iron, aqua carbonate hydroxy охо 
starch  sucrose  complex  (CAS  number:  1041180-02-2),  (Lenziaren),  to  be  used  as  zootechnical 
additive. (Table 1) 
Table 1:   Description of the substances 
Category of additive  Zootechnical additives 
Functional group of additive  Other zootechnical additives 
Trade name  Lenziaren 
Description  Iron, aqua carbonate hydroxy oxo starch sucrose complex (CAS number: 
1041180-02-2) 
Target animal category  Cats 
Applicant  Novartis 
Type of request  Update opinion 
 
On 16th April 2013, the Authority gave an opinion on the efficacy of the product. It was concluded 
that the product showed an efficacy reduction in serum phosphorus or in urinary phosphate at the 
highest  dose  recommended  by  the  applicant.  However,  the  applicant  strongly  supports  for  an 
authorisation on its product at the minimum proposed dosage. Since no safety concerns are involved, 
the  Commission  gave  the  possibility  to  the  applicant  to  submit  complementary  information  to 
complete the assessment on efficacy to allow a revision of that opinion. 
The Commission has now received an additional dossier from the applicant on iron, aqua carbonate 
hydroxy охо starch sucrose complex (CAS number: 1041180-02-2), (Lenziaren) with supplementary 
information, concerning the efficacy studies of the additive. 
The Commission, in order to give the appropriate follow-up to the applications, asks the Authority to 
issue an updated opinion on the safety of this product under the terms of reference specified in the 
Annex. 
The data generated by the applicant and compiled in the above-mentioned supplementary reports have 
been sent directly to Authority by the applicant.
7  
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In view of the above, the Commission asks the Authority to deliver an opinion on efficacy of iron, 
aqua carbonate hydroxy охо starch sucrose complex (CAS number: 1041180-02-2) (Lenziaren) as 
zootechnical additive submitted by Novartis. 
                                                       
5  Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use 
in animal nutrition. OJ L 268, 18.10.2003, p. 29. 
6  Novartis Animal Health UK Limited, Frimley Business Park, Frimley/Camberley, Surrey GU16 7SR, United Kingdom. 
7  EFSA Dossier reference: FAD-2014-0003. Lenziaren for cats 
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ASSESSMENT 
1.  Introduction 
Lenziaren is a polynuclear Fe(III) starch–saccharose complex that is intended to act as an intestinal 
phosphate binder in adult cats. The additive is intended to be administered in addition to cat food and 
mixed by the cat owner once a day to give a daily dose of 0.25–1.0 g/cat. In dry food, Lenziaren 
should be added to achieve a concentration of 5 g/kg cat food, which can be increased to 20 g/kg of 
dry food if necessary (this assumes 50 g of dry food per cat per day with an 88 % dry matter content). 
In wet food, Lenziaren should be mixed into cat food to achieve a concentration of 1.25 g/kg of wet 
food, which can be increased to 5 g/kg of wet food if necessary (this assumes 200 g of wet food per cat 
per day with a 22 % dry matter content). The applicant recommends that the additive is not used 
during pregnancy and lactation. 
The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) delivered an 
opinion on the safety and efficacy of this additive when used in food for cats (EFSA FEEDAP Panel, 
2013).  In  that  opinion,  the  Panel  could  only  conclude  that  “Lenziaren  has  the  potential  to  be 
efficacious in cats at the highest recommended dose of 1 g/cat and day (equivalent to 20 000 mg/kg 
complete feed). However, the FEEDAP Panel has some reservations regarding the value of its long-
term use in healthy cats”. There was insufficient evidence of efficacy at the lowest dose of 0.25 g/cat 
per day. 
The applicant has provided new data to support the efficacy of the additive at the minimum proposed 
dose of 0.25 g/cat per day, equivalent to 5 g/kg complete feed. 
2.  Efficacy
8 
In  the  previous  opinion  (EFSA  FEEDAP  Panel,  2013),  three  studies  showed  either  a  significant 
reduction in serum phosphorus or a reduction in urinary phosphate, suggesting a significant binding of 
phosphate at the intestinal level. Two of these studies showed a significant reduction at 0.25 g/cat per 
day, while the third one only showed an effect at a level of 1 g/cat per day. Therefore, the Panel 
concluded that the minimum effective dose was 1 g/cat and day, equivalent to 20 g/kg complete feed. 
The applicant has provided a new study in order to support the efficacy of the lowest recommended 
dose (0.25 g/cat per day, equivalent to 5 g/kg complete feed). 
A total of 24 healthy European shorthair adult cats were distributed into two treatment groups. Each 
group consisted of six males and six females. The cats were offered a dry cat renal diet (phosphorus 
content not specified) either supplemented (top dressing) or not with Lenziaren at a dose of 0.25 g/cat 
per day. The experimental period lasted for 28 days (days 0–28), during which each cat was offered an 
individual ration. All animals were monitored daily. Food intake was recorded daily and animals were 
weighed weekly. Blood was collected for haematology and blood chemistry parameters.
9 Urine was 
collected from litter trays for urine analysis. Data were analysed using a repeated measures analysis of 
covariance using the cat as the experimental unit. The pre-treatment values were used as a covariate. 
No differences in food consumption  or body weight  were observed between treatments during the 
experiment.  Overall urine inorganic phosphorus concentrations significantly decreased in treated 
animals compared with control animals. These results were observed in males but not in females. The 
applicant states that females avoided consumption o f some of the additive, which could explain, in 
part at least, the observed differences between sexes.  The Panel is not aware of any physiological 
                                                       
8  This section has been edited following the confidentiality claims made by the applicant. 
9  Erythrocytes, haemoglobin, haematocrit,  mean corpuscular volume, mean corpuscular haemoglobin, mean corpuscular 
haemoglobin  concentration,  thrombocytes,  leucocytes,  neutrophils,  lymphocytes,  monocytes,  eosinophils,  basophils, 
sodium,  potassium,  chloride,  calcium,  inorganic  phosphorus,  magnesium,   total  protein,  albumin,  globulin,  glucos e, 
amylase,  urea  nitrogen,  creatinine,  alanine  aminotransferase,  aspartate  aminotransferase,  lactate  dehydrogenase, 
prothrombin time, gamma-glutamyltransferase, fibrinogen, alkaline phosphat ase, activated partial th romboplastin time, 
creatine kinase, bile acids, total bilirubin and cholesterol. Lenziaren for cats 
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differences  between  sexes  in  terms  of  intestinal  phosphate  binding,  and  the  Panel  notes  that  sex 
differences were not explored in the efficacy studies evaluated in the previous opinion. No statistical 
differences  were  seen  in  any  of  the  other  urine  parameters  measured,  or  in  serum  phosphorus 
concentrations. 
The observed effect on urine inorganic phosphorus concentration suggests that the additive binds oral 
phosphate in cats at the tested dose of 0.25 g/cat per day. 
CONCLUSIONS 
Considering the two previous studies, which showed an effect at 0.25 g/cat per day, and the results of 
the new study, the FEEDAP Panel considers that Lenziaren has the potential to be efficacious in 
binding intestinal phosphorus at the minimum recommended dose of 0.25 g/cat per day (equivalent to 
5 g/kg complete feed). The Panel still has the reservations expressed in the previous opinion regarding 
the value of the long-term use of the additive in healthy cats. 
DOCUMENTATION PROVIDED TO EFSA 
1.  Lenziaren.  Supplementary  efficacy  information  on  Lenziaren.  January  2014.  Submitted  by 
Novartis Animal Health. 
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